EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Evaluation of the 2021 ESC Recommendations for Family Screening in Hereditary Transthyretin Cardiac Amyloidosis

Steven A Muller iD, Belén Peiró-Aventin, Giulia Biagioni, Giacomo Tini, Giulia Saturi, Christina Kronberger, Anouk Achten, Stephan Dobner, Wouter P Te Rijdt, Alessio Gasperetti, Anneline S J M Te Riele iD, Guerino G Varrà und 22 weitere

European Journal of Heart Failure · 01.09.2024 · 26 (9) · 2025-2034

DOI: 10.1002/ejhf.3339 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Heart Failure, online erschienen am 17.06.2024. Verfasst von Steven A Muller und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Cardiomyopathies. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Netherlands Heart Foundation, Italian Ministry of Health, ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The 2021 European Society of Cardiology (ESC) screening recommendations for individuals carrying a pathogenic transthyretin amyloidosis variant (ATTRv) are based on expert opinion. We aimed to (i) determine the penetrance of ATTRv cardiomyopathy (ATTRv-CM) at baseline; (ii) examine the value of serial evaluation; and (iii) establish the yield of first-line diagnostic tests (i.e. electrocardiogram, echocardiogram, and laboratory tests) as per 2021 ESC position statement. Methods and results We included 159 relatives (median age 55.6 [43.2–65.9] years, 52% male) at risk for ATTRv-CM from 10 centres. The primary endpoint, ATTRv-CM diagnosis, was defined as the presence of (i) cardiac tracer uptake in bone scintigraphy; or (ii) transthyretin-positive cardiac biopsy. The secondary endpoint was a composite of heart failure (New York Heart Association class ≥II) and pacemaker-requiring conduction disorders. At baseline, 40/159 (25%) relatives were diagnosed with ATTRv-CM. Of those, 20 (50%) met the secondary endpoint. Indication to screen (≤10 years prior to predicted disease onset and absence of extracardiac amyloidosis) had an excellent negative predictive value (97%). Other pre-screening predictors for ATTRv-CM were infrequently identified variants and male sex. Importantly, 13% of relatives with ATTRv-CM did not show any signs of cardiac involvement on first-line diagnostic tests. The yield of serial evaluation (n = 41 relatives; follow-up 3.1 [2.2–5.2] years) at 3-year interval was 9.4%.

Conclusions

Screening according to the 2021 ESC position statement performs well in daily clinical practice. Clinicians should adhere to repeating bone scintigraphy after 3 years, as progressing to ATTRv-CM without signs of ATTRv-CM on first-line diagnostic tests or symptoms is common.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialCardiomyopathiesHumansMaleFemaleMiddle AgedAgedAdultEuropeEchocardiographyElectrocardiographyPrealbuminGenetic TestingMass ScreeningPractice Guidelines as TopicCardiologySocieties, Medical

Stichwörter der Autor:innen

ATTRvAmyloidosisCascade screeningRepeat evaluation

Substanzen

Prealbumin

Autor:innen und Institutionen

  • Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Netherlands Heart Institute, Utrecht, The Netherlands.
  • Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).
  • Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, CIBERCV, Madrid, Spain.
  • Tuscan Regional Amyloid Centre, Careggi University Hospital, Florence, Italy.
  • Cardiology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.

ORCID-Profile: Steven A Muller, Anneline S J M Te Riele, Marish I F J Oerlemans

Förderung

  • Netherlands Heart Foundation
  • Italian Ministry of Health
  • ZonMw
  • European Research Council
  • Ministero della Salute

Zitieren

APA

Muller, S. A., Peiró-Aventin, B., Biagioni, G., Tini, G., Saturi, G., Kronberger, C., Achten, A., Dobner, S., Te Rijdt, W. P., Gasperetti, A., Te Riele, A. S. J. M., Varrà, G. G., Ponziani, A., Hirsch, A., Porcari, A., van der Meer, M. G., Zampieri, M., van der Harst, P., Kammerlander, A., …, & Oerlemans, M. I. F. J. (2024). Evaluation of the 2021 ESC Recommendations for Family Screening in Hereditary Transthyretin Cardiac Amyloidosis. European Journal of Heart Failure, 26(9), 2025-2034. https://doi.org/10.1002/ejhf.3339

Vancouver

Muller SA, Peiró-Aventin B, Biagioni G, Tini G, Saturi G, Kronberger C, et al. Evaluation of the 2021 ESC Recommendations for Family Screening in Hereditary Transthyretin Cardiac Amyloidosis. European Journal of Heart Failure. 2024;26(9):2025-2034. doi:10.1002/ejhf.3339

BibTeX
@article{Muller2024,
  author = {Muller, Steven A and Peiró-Aventin, Belén and Biagioni, Giulia and Tini, Giacomo and Saturi, Giulia and Kronberger, Christina and Achten, Anouk and Dobner, Stephan and Te Rijdt, Wouter P and Gasperetti, Alessio and Te Riele, Anneline S J M and Varrà, Guerino G and Ponziani, Alberto and Hirsch, Alexander and Porcari, Aldostefano and van der Meer, Manon G and Zampieri, Mattia and van der Harst, Pim and Kammerlander, Andreas and Biagini, Elena and van Tintelen, J Peter and Barbato, Emanuele and Asselbergs, Folkert W and Menale, Silvia and Gräni, Christoph and Merlo, Marco and Michels, Michelle and Knackstedt, Christian and Nitsche, Christian and Longhi, Simone and Musumeci, Beatrice and Cappelli, Francesco and Garcia-Pavia, Pablo and Oerlemans, Marish I F J},
  title = {Evaluation of the 2021 ESC Recommendations for Family Screening in Hereditary Transthyretin Cardiac Amyloidosis},
  journal = {European Journal of Heart Failure},
  year = {2024},
  volume = {26},
  number = {9},
  pages = {2025--2034},
  doi = {10.1002/ejhf.3339}
}
Kostenlos starten →